36C77020Q0013-002.xlsx
XLSX spreadsheet 24 KB Posted
- Attached to
- 7 Pharmaceuticals
- Solicitation number
- 36C77020Q0013
About this file
36C77020Q0013 Q0013 - Pricing Schedule - 7 LI MISC PHARMS - 10.02.19.xlsx
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C77020Q0013-0001000.docx | DOCX document | |
| 36C77020Q0013-0001000.docx | DOCX document | |
| 36C77020Q0013-001.docx | DOCX document | |
| 36C77020Q0013-002.xlsx | XLSX spreadsheet | |
| 36C77020Q0013-001.docx | DOCX document | |
| 36C77020Q0013-000.docx | DOCX document | |
| 36C77020Q0013-000.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Pharmacy List
| Pharmaceuticals | Posted | |
| VA CMOP - | MURFREESBORO CMOP | 10/03/2019 |
| Solicitation # 36C77020Q0013 | Due Date | |||||||
| 1) Full Delivery required within 3 days ARO, no partials accepted without prior approval | 10/04 @ 5PM | |||||||
| 2) All NDCs submitted for bid will need to pass RPH evaluation and approval | ||||||||
| Vendor Name: | ||||||||
| Vendor Point of Contact: | ||||||||
| Point of Contact Email: | ||||||||
| LINE ITEM | NDC #/UPC | CMOP | ||||||
| Item # | DESCRIPTION | VENDOR PROPOSED ALTERNATE | ||||||
| NDC (PKG SZ) | MFR. | COUNTRY OF | ||||||
| ORIGIN | PKG | QTY | UNIT OF | |||||
| MEASURE | UNIT PRICE | TOTAL PRICE | VENDOR COMMENTS (DELIVERY SCHEDULE) | |||||
| 1 | 33342-0067-07 | O0079 | OLANZAPINE 2.5MG TAB | 30 | 360 | BT | ||
| 2 | 33342-0068-07 | O0073 | OLANZAPINE 5MG TAB | 30 | 480 | BT | ||
| 3 | 43598-0165-30 | O0074 | OLANZAPINE 7.5MG TAB | 30 | 144 | BT | ||
| 4 | 33342-0070-15 | O0075 | OLANZAPINE 10MG TAB | 500 | 48 | BT | ||
| 5 | 67877-0416-90 | V0113 | VALSARTAN 80MG TAB | 90 | 72 | BT | ||
| 6 | 68462-0292-01 | V0054 | VERAPAMIL HCL 120MG SA TAB | 100 | 168 | BT | ||
| 7 | 68462-0260-05 | V0010 | VERAPAMIL HCL 240MG SA TAB | 500 | 156 | BT |
Abstract of Offerors
| Pharmaceuticals |
| VA CMOP - |
| Solicitation # | |
| 1) Full Delivery required within 5 days ARO, no partials accepted without prior approval | |
| 2) All NDCs submitted for bid will need to pass RPH evaluation and approval |
| LINE ITEM | NDC #/UPC | CMOP | ||||||||||||||||||||||||||||||||||||||||||
| Item # | DESCRIPTION | ACCEPTABLE ALT NDC'S | PKG | QTY | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE | NDC Proposed | MFR. | ORIGIN COUNTRY | UNIT PRICE | TOTAL PRICE |
| 1 | ||||||||||||||||||||||||||||||||||||||||||||
| 2 | ||||||||||||||||||||||||||||||||||||||||||||
| 3 | ||||||||||||||||||||||||||||||||||||||||||||
| 4 | ||||||||||||||||||||||||||||||||||||||||||||
| 5 |
Vendor DUNS # SAM expiration Date Socio economic size Past Performance Rating PPIRS
Awards
| Pharmaceuticals | Posted |
| VA CMOP - |
Solicitation # Due Date
| Delivery to be 10 Days ARO | |||||||||
| LINE ITEM | NDC #/UPC | IMF# | CMOP | ||||||
| Item # | DESCRIPTION | BT SZ | UNIT | QTY | IGCE | Vendor Alt NDC | MFR. | COUNTRY OF | |
| ORIGIN | UNIT PRICE | TOTAL PRICE | |||||||
| Socio-economic Size | eCMS PO # | ||||||||
| Awd PO # Awd 2237 | |||||||||
| -- DUNS | $0.00 | ||||||||
| $0.00 | |||||||||
| -- DUNS | Awd PO # Awd 2237 | eCMS PO# | |||||||
| $0.00 | |||||||||
| $0.00 | |||||||||
| -- DUNS | Awd PO # Awd 2237 | eCMS PO# | |||||||
| $0.00 | |||||||||
| $0.00 | |||||||||
| $0.00 | |||||||||
| -- DUNS | Awd PO # Awd 2237 | eCMS PO# | |||||||
| $0.00 | |||||||||
| $0.00 | |||||||||
| $0.00 | |||||||||
| $0.00 | |||||||||
| Awd PO # Awd 2237 | eCMS PO# | ||||||||
| -- DUNS | $0.00 | ||||||||
| $0.00 | |||||||||
| $0.00 |
File details come from the government source that posted it.